These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16928420)

  • 1. Performance of a new substance dependence screening questionnaire (SDSQ) in a non-clinical population.
    Vázquez FL; Blanco V; López M
    Addict Behav; 2007 May; 32(5):1082-7. PubMed ID: 16928420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample.
    Dodd S; Williams LJ; Jacka FN; Pasco JA; Bjerkeset O; Berk M
    Aust N Z J Psychiatry; 2009 Jun; 43(6):526-30. PubMed ID: 19440884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for drug use disorders in the emergency department: performance of the rapid drug problems screen (RDPS).
    Cherpitel CJ; Borges G
    Drug Alcohol Depend; 2004 May; 74(2):171-5. PubMed ID: 15099660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders.
    Zimmerman M; Sheeran T; Chelminski I; Young D
    J Subst Abuse Treat; 2004 Apr; 26(3):181-8. PubMed ID: 15063911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine in adolescents: validation of a screening questionnaire.
    Valentinis L; Valent F; Mucchiut M; Barbone F; Bergonzi P; Zanchin G
    Headache; 2009 Feb; 49(2):202-11. PubMed ID: 19222594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and validation of the Indigenous Risk Impact Screen (IRIS): a 13-item screening instrument for alcohol and drug and mental health risk.
    Schlesinger CM; Ober C; McCarthy MM; Watson JD; Seinen A
    Drug Alcohol Rev; 2007 Mar; 26(2):109-17. PubMed ID: 17364845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests of a symptom checklist to screen for comorbid psychiatric disorders in alcoholism.
    Benjamin AB; Mossman D; Graves NS; Sanders RD
    Compr Psychiatry; 2006; 47(3):227-33. PubMed ID: 16635653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Hopkins telephone diagnostic interview for restless legs syndrome.
    Hening WA; Allen RP; Washburn M; Lesage S; Earley CJ
    Sleep Med; 2008 Mar; 9(3):283-9. PubMed ID: 17644424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Appraisal of Individual Needs Short Screener (GSS): psychometric properties and performance as a screening measure in adolescents.
    McDonell MG; Comtois KA; Voss WD; Morgan AH; Ries RK
    Am J Drug Alcohol Abuse; 2009; 35(3):157-60. PubMed ID: 19462299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a self-administered modified CAGE test (CAGE-C) in a somatic hospital ward: comparison with biochemical markers.
    Zierau F; Hardt F; Henriksen JH; Holm SS; Jørring S; Melsen T; Becker U
    Scand J Clin Lab Invest; 2005; 65(7):615-22. PubMed ID: 16271993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adaptation of the Center for Epidemiologic Studies Depression Scale for use in non-psychiatric Spanish populations.
    Vázquez FL; Blanco V; López M
    Psychiatry Res; 2007 Jan; 149(1-3):247-52. PubMed ID: 17141880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders.
    Jordan BK; Karg RS; Batts KR; Epstein JF; Wiesen C
    Addict Behav; 2008 Jun; 33(6):782-98. PubMed ID: 18262368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the use and career histories of drug users in treatment: reliability of the Lifetime Drug Use History (LDUH) and its data yield relative to clinical case notes.
    Day E; Best D; Cantillano V; Gaston RL; Nambamali A; Keaney F
    Drug Alcohol Rev; 2008 Mar; 27(2):171-7. PubMed ID: 18264878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for anxiety disorders. Sensitivity and specificity of the Anxiety Screening Questionnaire (ASQ-15).
    Wittchen HU; Boyer P
    Br J Psychiatry Suppl; 1998; (34):10-7. PubMed ID: 9829011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Turkish version of the mood disorder questionnaire for screening bipolar disorders].
    Konuk N; Kiran S; Tamam L; Karaahmet E; Aydin H; Atik L
    Turk Psikiyatri Derg; 2007; 18(2):147-54. PubMed ID: 17566880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire.
    Picardi A; Abeni D; Mazzotti E; Fassone G; Lega I; Ramieri L; Sagoni E; Tiago A; Pasquini P
    J Psychosom Res; 2004 Sep; 57(3):219-23. PubMed ID: 15507245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
    Whelan-Goodinson R; Ponsford J; Schönberger M
    J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for borderline personality disorder in outpatient youth.
    Chanen AM; Jovev M; Djaja D; McDougall E; Yuen HP; Rawlings D; Jackson HJ
    J Pers Disord; 2008 Aug; 22(4):353-64. PubMed ID: 18684049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.